-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IukezvubHazoLfUcEiOcs2+MhM8aYI3c53aBQ3/4pXMsyKfuyk7UYgIY5UsgVhkt 1sZ7JfUrgzLu1NsFJiNQSg== 0000062391-97-000009.txt : 19970222 0000062391-97-000009.hdr.sgml : 19970222 ACCESSION NUMBER: 0000062391-97-000009 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970212 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GENSIA INC CENTRAL INDEX KEY: 0000807873 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330176647 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43145 FILM NUMBER: 97525622 BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121-3030 BUSINESS PHONE: 6195468300 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: GENSIA PHARMACEUTICAL INC DATE OF NAME CHANGE: 19930701 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HOECHST MARION ROUSSEL INC CENTRAL INDEX KEY: 0000062391 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 440565557 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 10236 MARION PARK DRIVE STREET 2: P O BOX 9627 CITY: KANSAS CITY STATE: MO ZIP: 64134-0627 BUSINESS PHONE: 8169665000 MAIL ADDRESS: STREET 1: 10236 MARION PARK DRIVE STREET 2: P O BOX 9627 CITY: KANSAS CITY STATE: MO ZIP: 64134-0627 FORMER COMPANY: FORMER CONFORMED NAME: MARION MERRELL DOW INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: MARION LABORATORIES INC DATE OF NAME CHANGE: 19891218 SC 13G/A 1 HMRI AMENDMENT 4 TO GENSIA, INC. 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 4) GENSIA, INC. ---------------------------- (Name of Issuer) Common Stock par value $.01 per share - --------------------------------------------------------------------------- (Title of Class of Securities) 372450 10 6 ----------------- (CUSIP Number) Check the following box if a fee is being paid with this statement [ ]. Page 1 of 4 There is no Exhibit Index 2 CUSIP No. 372450 10 6 ___________________________________________________________________________ 1) Name of Reporting Person and its Hoechst Marion Roussel, Inc. I.R.S. Identification Number 44-0565557 ___________________________________________________________________________ 2) Check the Appropriate Box if (a)[ ] a Member of a Group (b)[ x ] ___________________________________________________________________________ 3) SEC Use Only ___________________________________________________________________________ 4) Citizenship or Place of Organization Delaware ___________________________________________________________________________ 5) Sole Voting Power 3,396,442 Number of ____________________________________________________________ Shares Beneficially 6) Shared Voting Power 0 Owned by ____________________________________________________________ Each Reporting 7) Sole Dispositive Power 3,396,442 Person With ____________________________________________________________ 8) Shared Dispositive Power 0 ___________________________________________________________________________ 9) Aggregate Amount Beneficially Owned 3,396,442 by Each Reporting Person ___________________________________________________________________________ 10) Check Box If the Aggregate Amount [ ] in Row (9) Excludes Certain Shares ___________________________________________________________________________ 11) Percent of Class Represented 8.4% by Amount in Row (9) ___________________________________________________________________________ 12) Type of Reporting Person CO ___________________________________________________________________________ 3 This Amendment No. 4 amends the Statement on Schedule 13G (the "Schedule 13G") of Hoechst Marion Roussel, Inc. ("HMRI", formerly named Marion Merrell Dow Inc.) dated February 11, 1992, as amended through the date hereof. This amendment is filed solely to report a change of record ownership (but not ultimate beneficial ownership) of the outstanding stock of HMRI and to adjust HMRI's percentage ownership of the Issuer's common stock due to an increase in the number of shares of the Issuer's common stock outstanding. Effective December 31, 1996, Hoechst Corporation ("HC"), a wholly-owned subsidiary of Hoechst Aktiengesellschaft, a German corporation ("Hoechst AG"), conveyed its entire ownership interest in HMRI to HMR Pharma, Inc. ("Pharma"), also a wholly-owned subsidiary of Hoechst AG, in a reorganization among controlled affiliates of Hoechst AG. Following the reorganization, Pharma's ownership interest in HMRI is approximately 98 percent. Pharma has filed a Statement on Schedule 13D with respect to its potential deemed beneficial ownership of the Issuer's common stock as a result of Pharma's ownership of HMRI. Item 4 of this Schedule 13G is hereby amended by inserting new subsection (b) thereof as follows: Item 4 Ownership - ------ --------- (b) Percent of Class: 8.4% 4 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. HOECHST MARION ROUSSEL, INC. Date: February 6, 1997 By: /s/ Rebecca R. Tilden ----------------------- Name: Rebecca R. Tilden Title: Vice President, Assistant General Counsel, and Assistant Secretary -----END PRIVACY-ENHANCED MESSAGE-----